Authors: Leichman, L Leichman, CG

Citation: L. Leichman et Cg. Leichman, Therapy of disseminated colorectal cancer: The emerging role of intratumoral molecular biology, EURO J SURG, 167, 2001, pp. 43-48

Authors: Gergel, T Proulx, G Leichman, L Nava, H Kuettel, M

Citation: T. Gergel et al., Diagnostic dilemmas in oncology - Case 3. Pericardial effusion after esophageal radiation, J CL ONCOL, 19(23), 2001, pp. 4344-4345

Authors: Garcia, AA Leichman, CG Lenz, HJ Baranda, J Lujan, R Casagrande, Y Leichman, L

Citation: Aa. Garcia et al., Phase II trial of outpatient schedule of paclitaxel in patients with previously untreated metastatic, measurable adenocarcinoma of the stomach, JPN J CLIN, 31(6), 2001, pp. 275-278

Authors: Salonga, D Danenberg, KD Johnson, M Metzger, R Groshen, S Tsao-Wei, DD Lenz, HJ Leichman, CG Leichman, L Diasio, RB Danenberg, PV

Citation: D. Salonga et al., Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase, CLIN CANC R, 6(4), 2000, pp. 1322-1327

Authors: Koda, RT Garcia, AA Chatterjee, DJ Li, WY Parimoo, D Jeffers, S Rogers, M Leichman, CG Leichman, L Wu, EY Shetty, BV Webber, S Clendinnin, N Muggia, FM

Citation: Rt. Koda et al., Phase I study of AG 331, a novel thymidylate synthase inhibitor, in patients with refractory solid tumors, CANC CHEMOT, 43(6), 1999, pp. 489-496